{"id":47974,"date":"2022-09-05T17:01:50","date_gmt":"2022-09-05T15:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/"},"modified":"2022-09-05T17:01:50","modified_gmt":"2022-09-05T15:01:50","slug":"global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/","title":{"rendered":"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Diabetic Neuropathy Clinical Trial Pipeline Highlights – 2022”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nDiabetic Neuropathy Pipeline Highlights Report 2022 provides the most up-to-date information on key pipeline products within the global Diabetic Neuropathy market. It covers emerging therapies for Diabetic Neuropathy in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.\n<\/p>\n

\nClinical Trial Stages:<\/strong>\n<\/p>\n

\nThe report provides Diabetic Neuropathy pipeline products by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.\n<\/p>\n

\nDrug Mechanism Classes:<\/strong>\n<\/p>\n

\nThe report provides Diabetic Neuropathy pipeline products by their dominant mechanism of action\/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.\n<\/p>\n

\nCompany:<\/strong>\n<\/p>\n

\nThe report provides Diabetic Neuropathy pipeline products by the company.\n<\/p>\n

\nShort-term Launch Highlights:<\/strong>\n<\/p>\n

\nFind out which Diabetic Neuropathy pipeline products will be launched in the US and Ex-US till 2025.\n<\/p>\n

\nKey Topics Covered:<\/strong>\n<\/p>\n

\n1. Diabetic Neuropathy Pipeline by Stages\n<\/p>\n

\n2. Diabetic Neuropathy Phase 3 Clinical Trial Insights\n<\/p>\n

\n3. Diabetic Neuropathy Phase 2 Clinical Trial Insights\n<\/p>\n

\n4. Diabetic Neuropathy Phase 1 Clinical Trial Insights\n<\/p>\n

\n5. Diabetic Neuropathy Preclinical Research Insights\n<\/p>\n

\n6. Diabetic Neuropathy Discovery Stage Insights\n<\/p>\n

\n7. Appendix\n<\/p>\n

\n8. Research Methodology\n<\/p>\n

\nFor more information about this report visit https:\/\/www.researchandmarkets.com\/r\/3s6jhs<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nResearchAndMarkets.com
\n
Laura Wood, Senior Press Manager
\n
press@researchandmarkets.com<\/a>
For E.S.T Office Hours Call 1-917-300-0470
\n
For U.S.\/ CAN Toll Free Call 1-800-526-8630
\n
For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DUBLIN–(BUSINESS WIRE)–The “Global Diabetic Neuropathy Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. Diabetic Neuropathy Pipeline Highlights Report 2022 provides the most up-to-date information on key pipeline products within the global Diabetic Neuropathy market. It covers emerging therapies for Diabetic Neuropathy in active clinical development stages including early and late … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47974","6":"format-standard","7":"category-industry"},"yoast_head":"\nGlobal Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN–(BUSINESS WIRE)–The “Global Diabetic Neuropathy Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. Diabetic Neuropathy Pipeline Highlights Report 2022 provides the most up-to-date information on key pipeline products within the global Diabetic Neuropathy market. It covers emerging therapies for Diabetic Neuropathy in active clinical development stages including early and late ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-05T15:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220905005344\/en\/1561419\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 – ResearchAndMarkets.com\",\"datePublished\":\"2022-09-05T15:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/\"},\"wordCount\":302,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005344\\\/en\\\/1561419\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/\",\"name\":\"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005344\\\/en\\\/1561419\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-05T15:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005344\\\/en\\\/1561419\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005344\\\/en\\\/1561419\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 – ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN–(BUSINESS WIRE)–The “Global Diabetic Neuropathy Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. Diabetic Neuropathy Pipeline Highlights Report 2022 provides the most up-to-date information on key pipeline products within the global Diabetic Neuropathy market. It covers emerging therapies for Diabetic Neuropathy in active clinical development stages including early and late ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-05T15:01:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220905005344\/en\/1561419\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 – ResearchAndMarkets.com","datePublished":"2022-09-05T15:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/"},"wordCount":302,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220905005344\/en\/1561419\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/","name":"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220905005344\/en\/1561419\/21\/logo.jpg","datePublished":"2022-09-05T15:01:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220905005344\/en\/1561419\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220905005344\/en\/1561419\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-diabetic-neuropathy-clinical-trial-pipeline-research-report-2022-with-short-term-highlights-launched-in-the-us-and-ex-us-to-2025-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Diabetic Neuropathy Clinical Trial Pipeline Research Report 2022 with Short-term Highlights Launched in the US and Ex-US to 2025 – ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47974"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47974\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}